Table 2.

Demographic and clinical characteristics of patients included in the longitudinal peripheral blood analysis.

Median age (range), years	57 (34–77)
Male, No. (%)	2 (28)
ICIs, No.
PD-1 inhibitor	5
Combined CTLA-4 and PD-1 inhibitors	2
Median time from first to second sample collection (range), weeks	7 (3–15)
Arthritis treatment at the time of second blood sample collection, No.
Steroid monotherapy	3
Steroid plus methotrexate	1
Steroid plus tocilizumab	2
Steroid plus infliximab	1
Median maximum dose of prednisone (or equivalent) between the first and second sample collections (range), mg	20 (10–135)